𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interleukin 2 treatment does not modify hepatitis B or C replication in human immunodeficiency virus–infected patients: Results from a randomized control trial

✍ Scribed by Vincent Thibault; Constance Delaugerre; Vincent Calvez; Dominique Costagliola; Roland Tubiana; Christine Katlama

Book ID
111721703
Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
216 KB
Volume
35
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II randomized, double-blind, pla
A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA
📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB